|
⚲
|
| Keyboard |
| Northcott John
✚
|
|
|---|---|
| CIK # | 0001615000 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001615000] | |
| 4 | [0001615000] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Northcott John | |
| Nektar Therapeutics | |
| Lexicon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nektar Therapeutics NKTR
Common Stock
|
2022-05-16 | Sell | 4,592 | $3.95 | 18,138 |
|
Nektar Therapeutics NKTR
Common Stock
|
2022-02-16 | Sell | 4,852 | $10.95 | 53,129 |
|
Nektar Therapeutics NKTR
Common Stock
|
2021-12-16 | Grant | 37,800 | $0.00 | |
|
Nektar Therapeutics NKTR
Stock Option · derivative
|
2021-12-16 | Grant | 67,150 | $0.00 | |
|
Nektar Therapeutics NKTR
Common Stock
|
2021-11-16 | Sell | 6,061 | $13.16 | 79,763 |
|
Nektar Therapeutics NKTR
Common Stock
|
2021-08-16 | Sell | 6,192 | $13.83 | 85,635 |
|
Nektar Therapeutics NKTR
Common Stock
|
2021-05-17 | Sell | 6,085 | $18.30 | 111,356 |
|
Nektar Therapeutics NKTR
Common Stock
|
2021-02-16 | Sell | 15,358 | $22.37 | 343,558 |
|
Nektar Therapeutics NKTR
Stock Option · derivative
|
2020-12-18 | Grant | 51,000 | $0.00 | |
|
Nektar Therapeutics NKTR
Common Stock
|
2020-12-18 | Grant | 28,550 | $0.00 | |
|
Nektar Therapeutics NKTR
Common Stock
|
2019-12-02 | Grant | 200,000 | $0.00 | |
|
Nektar Therapeutics NKTR
Stock Option · derivative
|
2019-12-02 | Grant | 200,000 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units (Phantom Stock) · derivative
|
2015-03-02 | Option exercise | 11,250 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2015-03-02 | Tax withheld | 3,015 | $0.94 | 2,834 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2015-03-02 | Option exercise | 11,250 | ||
|
Lexicon Pharmaceuticals Inc LXRX
Restricted Stock Units (Phantom Stock) · derivative
|
2015-02-05 | Grant | 120,600 | $0.00 | |
|
Lexicon Pharmaceuticals Inc LXRX
Stock Option (Right to Buy) · derivative
|
2015-02-05 | Grant | 482,400 | $0.00 |